Novartis US Highlights Patient-Centered Focus Ahead of ASCO 2025
May 31, 2025, 04:30

Novartis US Highlights Patient-Centered Focus Ahead of ASCO 2025

Novartis US posted on LinkedIn:

“How can we better partner with the next generation of oncology patients?​
At the American Society of Clinical Oncology (ASCO) Meeting, we’re showing up to listen and learn from the oncology community on what the next generation of cancer patients is looking for.
See what you can anticipate from us at ASCO25.”

More posts featuring ASCO 2025.